Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia

BACKGROUND: Carbidopa (CD) and levodopa (LD) extended release (CD-LD ER) capsules are designed to combine both immediate and extended release pharmacokinetics. In the phase 3, randomized, double-blind, ADVANCE-PD trial, patients randomized to CD-LD ER experienced a 1.17-hour greater reduction in OFF...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Parkinsons Dis
Päätekijät: Hauser, Robert A., Zeitlin, Leonid, Fisher, Stanley, D’Souza, Richard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: IOS Press 2020
Aiheet:
Research Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458518/
https://ncbi.nlm.nih.gov/pubmed/32568108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-202010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia